Recently, a study done by Moderna Company states that the vaccine developed against covid by the Organisation is highly effective for teens aged 12 to 17. Notably, the company mentions that it plans that it will request the FDA to expand the emergency use of its covid-19 shots for teens, early next month. On the other hand, if they authorize, it would likely dramatically expand the number of shots available to middle and high school students forth of the next school year. Furthermore, Pfizer and German partner BioNTech were cleared to use their vaccine for 12- to 15-year-olds as soon as possible this month.
Stephane Bancel, the Moderna CEO in a press release said, “We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents.” He added that we remain committed to doing our part to help end the COVID-19 pandemic.
Hence, The two-dose vaccine, which is given four weeks apart, is already authorized for adults. Moreover, the company is citing Tuesday included more than 3,700 adolescents in the phase 2/3 study. According to the company, no even a single case for the covid-19 case was observed in the candidates who received two doses of the vaccination. However, the four cases were observed in the placebo group.
Moderna clarifies, that significantly, no safety concerns have been spotted and side effects generally are compatible with those seen in an earlier trial of adults. Also, the company officials said that the most common side effects after the second dose were headache, fatigue, muscle pain, and chills.
As per the government records, children make up around 20 percent of the total U.S. population. Few 70 percent to 85 percent of the U.S. population needs to be vaccinated against Covid to achieve herd immunity. Also, the medical experts say that some of the adults may refuse to get the shots. Though more experts now say herd immunity is looking increasingly unlikely as variants spread.